{"altmetric_id":2601945,"counts":{"readers":{"mendeley":21,"citeulike":0,"connotea":0},"news":{"unique_users_count":1,"unique_users":["nature"],"posts_count":1},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["MicrobLog_me_uk","Mary_Yianni"],"posts_count":2},"wikipedia":{"unique_users_count":1,"unique_users":["en:42176118"],"posts_count":1}},"citation":{"abstract":"CMX001 (hexadecyloxypropyl-cidofovir, Brincidofovir) is a broad spectrum, lipid conjugate of cidofovir that is converted intracellularly into the active antiviral, cidofovir diphosphate. The lipid conjugation results in oral bioavailability, higher intracellular concentrations of active drug, lower plasma concentrations of cidofovir and increased antiviral potency against dsDNA viruses.","abstract_source":"pubmed","altmetric_jid":"4f6fa6173cf058f6100073ca","authors":["Diana F Florescu"],"doi":"10.1586\/14787210.2014.948847","first_seen_on":"2014-08-19T00:17:22+00:00","issns":["1478-7210"],"journal":"Expert Review of Anti-Infective Therapy","last_mentioned_on":1442240536,"links":["http:\/\/informahealthcare.com\/doi\/abs\/10.1586\/14787210.2014.948847","http:\/\/dx.doi.org\/10.1586\/14787210.2014.948847","http:\/\/www.tandfonline.com\/doi\/abs\/10.1586\/14787210.2014.948847"],"pmid":"25120093","pubdate":"2014-08-16T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Immunology and Microbiology"],"subjects":["communicablediseases"],"title":"Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/development-cmx001-brincidofovir-treatment-serious-diseases-conditions-caused-dsdna-viruses"},"altmetric_score":{"score":15.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":15.75},"context_for_score":{"all":{"total_number_of_other_articles":6242464,"mean":5.9539850068813,"rank":356292,"this_scored_higher_than_pct":94,"this_scored_higher_than":5884660,"rank_type":"exact","sample_size":6242464,"percentile":94},"similar_age_3m":{"total_number_of_other_articles":140191,"mean":8.3607330622727,"rank":12040,"this_scored_higher_than_pct":91,"this_scored_higher_than":128135,"rank_type":"exact","sample_size":140191,"percentile":91},"this_journal":{"total_number_of_other_articles":487,"mean":2.9904156378601,"rank":14,"this_scored_higher_than_pct":97,"this_scored_higher_than":473,"rank_type":"exact","sample_size":487,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":20,"mean":8.6447368421053,"rank":2,"this_scored_higher_than_pct":90,"this_scored_higher_than":18,"rank_type":"exact","sample_size":20,"percentile":90}}},"demographics":{"poster_types":{"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":4,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":1,"Student  > Postgraduate":4,"Student  > Master":4,"Other":1,"Student  > Bachelor":4},"by_discipline":{"Medicine and Dentistry":10,"Chemistry":1,"Psychology":1,"Agricultural and Biological Sciences":6,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"GB":1},"mendeley":{"US":1,"DE":1,"ES":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/MicrobLog_me_uk\/status\/500277987841814528","license":"datasift","citation_ids":[2601945,2601945],"posted_on":"2014-08-15T13:49:01+00:00","author":{"name":"Abid Hussain","image":"https:\/\/pbs.twimg.com\/profile_images\/790280619746070528\/yk72D294_normal.jpg","description":"Medical Microbiologist, currently Director of Infection Prevention & Control @heartofengland #DIPC. **ALL TWEETS MY OWN**","id_on_source":"MicrobLog_me_uk","tweeter_id":"59750982","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":1131},"tweet_id":"500277987841814528"},{"url":"http:\/\/twitter.com\/Mary_Yianni\/statuses\/643429562043469824","license":"gnip","rt":["MicrobLog_me_uk"],"citation_ids":[2601945],"posted_on":"2015-09-14T14:22:16+00:00","author":{"name":"Mary Yianni","url":"http:\/\/explore.tandfonline.com\/content\/med\/medicine-hub\/expert-collection","image":"https:\/\/pbs.twimg.com\/profile_images\/491911101898952704\/RzEUEAGG_normal.jpeg","description":"Publisher, Expert Collection, Expert Review of Precision Medicine and Drug Development. Views expressed my own.","id_on_source":"Mary_Yianni","tweeter_id":"1922710770","geo":{"lt":null,"ln":null},"followers":303},"tweet_id":"643429562043469824"}],"wikipedia":[{"title":"Brincidofovir","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=628611749#altmetric_citation_1","license":"public","citation_ids":[2601945],"posted_on":"2014-10-07T08:46:55+00:00","summary":"Brincidofovir (CMX001) is an experimental antiviral drug being developed by Chimerix of Durham, NC, for the treatment of cytomegalovirus, adenovirus, smallpox, and ebolavirus infections.","page_url":"http:\/\/en.wikipedia.org\/?curid=42176118","wiki_lang":"en","author":{"name":"Wnt","url":"http:\/\/en.wikipedia.org\/wiki\/User:Wnt"}}],"news":[{"title":"Ebola: Embed research in outbreak response","url":"http:\/\/www.nature.com\/news\/ebola-embed-research-in-outbreak-response-1.18110","license":"public","citation_ids":[4365640,635631,2601945,2909489,1154705],"posted_on":"2015-08-05T00:00:00+00:00","summary":"Testing Ebola treatments in West Africa's epidemic happened too late. Research response during future outbreaks must be more nimble, says Trudie Lang.","author":{"name":"Nature","url":"http:\/\/www.nature.com\/nature","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/076\/normal\/image.png?1369859733"}}]}}